SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant Challenge

Coronavirus Disease 2019 (COVID-19), caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has highlighted the need for the rapid generation of efficient vaccines for emerging disease. Virus-like particles, VLPs, are an established vaccine technology that produces vi...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Edward Sullivan, Po-Yu Sung, Weining Wu, Neil Berry, Sarah Kempster, Deborah Ferguson, Neil Almond, Ian M. Jones, Polly Roy
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2022-04-01
Edice:	Viruses
Témata:	SARS COVID-19 coronavirus baculovirus VLP recombinant
On-line přístup:	https://www.mdpi.com/1999-4915/14/5/914
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!